1OGS | A:1-77,A:432-497; B:1-77,B:432-497 | HUMAN ACID-BETA-GLUCOSIDASE |
1Y7V | A:1-77,A:432-497; B:1-77,B:432-497 | X-RAY STRUCTURE OF HUMAN ACID-BETA-GLUCOSIDASE COVALENTLY BOUND TO CONDURITOL B EPOXIDE |
2F61 | A:1-77,A:432-497; B:1-77,B:432-497 | CRYSTAL STRUCTURE OF PARTIALLY DEGLYCOSYLATED ACID BETA-GLUCOSIDASE |
2J25 | A:1-77,A:432-497; B:1-77,B:432-497 | PARTIALLY DEGLYCOSYLATED GLUCOCERAMIDASE |
2NSX | A:1-77,A:432-497; B:1-77,B:432-497; C:1-77,C:432-497; D:1-77,D:432-497 | STRUCTURE OF ACID-BETA-GLUCOSIDASE WITH PHARMACOLOGICAL CHAPERONE PROVIDES INSIGHT INTO GAUCHER DISEASE |
2NT0 | A:1-77,A:432-497; B:1-77,B:432-497; C:1-77,C:432-497; D:1-77,D:432-497 | ACID-BETA-GLUCOSIDASE LOW PH, GLYCEROL BOUND |
2NT1 | A:1-77,A:432-497; B:1-77,B:432-497; C:1-77,C:432-497; D:1-77,D:432-497 | STRUCTURE OF ACID-BETA-GLUCOSIDASE AT NEUTRAL PH |
2V3D | A:1-77,A:432-497; B:1-77,B:432-497 | ACID-BETA-GLUCOSIDASE WITH N-BUTYL-DEOXYNOJIRIMYCIN |
2V3E | A:1-77,A:432-497; B:1-77,B:432-497 | ACID-BETA-GLUCOSIDASE WITH N-NONYL-DEOXYNOJIRIMYCIN |
2V3F | A:1-77,A:432-497; B:1-77,B:432-497 | ACID-BETA-GLUCOSIDASE PRODUCED IN CARROT |
2VT0 | A:1-77,A:432-497; B:1-77,B:432-496 | X-RAY STRUCTURE OF A CONJUGATE WITH CONDURITOL-BETA-EPOXIDE OF ACID-BETA-GLUCOSIDASE OVEREXPRESSED IN CULTURED PLANT CELLS |
3GXD | A:1-77,A:432-497; B:1-77,B:432-497; C:1-77,C:432-497; D:1-77,D:432-497 | CRYSTAL STRUCTURE OF APO ACID-BETA-GLUCOSIDASE PH 4.5 |
3GXF | A:1-77,A:432-497; B:1-77,B:432-497; C:1-77,C:432-497; D:1-77,D:432-497 | CRYSTAL STRUCTURE OF ACID-BETA-GLUCOSIDASE WITH ISOFAGOMINE AT NEUTRAL PH |
3GXI | A:1-77,A:432-497; B:1-77,B:432-497; C:1-77,C:432-497; D:1-77,D:432-497 | CRYSTAL STRUCTURE OF ACID-BETA-GLUCOSIDASE AT PH 5.5 |
3GXM | A:1-77,A:432-497; B:1-77,B:432-497; C:1-77,C:432-497; D:1-77,D:432-497 | CRYSTAL STRUCTURE OF ACID-BETA-GLUCOSIDASE AT PH 4.5, PHOSPHATE CRYSTALLIZATION CONDITION |
3RIK | A:1-77,A:432-497; B:1-77,B:432-497; C:1-77,C:432-497; D:1-77,D:432-497 | THE ACID BETA-GLUCOSIDASE ACTIVE SITE EXHIBITS PLASTICITY IN BINDING 3,4,5,6-TETRAHYDROXYAZEPANE-BASED INHIBITORS: IMPLICATIONS FOR PHARMACOLOGICAL CHAPERONE DESIGN FOR GAUCHER DISEASE |
3RIL | A:1-77,A:432-497; B:1-77,B:432-497; C:1-77,C:432-497; D:1-77,D:432-497 | THE ACID BETA-GLUCOSIDASE ACTIVE SITE EXHIBITS PLASTICITY IN BINDING 3,4,5,6-TETRAHYDROXYAZEPANE-BASED INHIBITORS: IMPLICATIONS FOR PHARMACOLOGICAL CHAPERONE DESIGN FOR GAUCHER DISEASE |